EUVIMEDOtkrijte EUVIMED
CrossrefInformacijska kartica

Reproducibility of Patch Test Reactions and Interpretation of Doubtful Results: A Retrospective Study of Identical Haptens Tested Simultaneously in Different Series

Norbertus A. Ipenburg, Anton C. de Groot, Thomas Rustemeyer

Contact Dermatitis · 2026-12 · 95 (6) · 588-597

DOI: 10.1111/cod.70251 ↗
SažetakBibliografski podaci

Sažetak

ABSTRACT Background Reproducibility of patch test reactions remains debated, and the clinical significance of doubtful (?+) reactions is unclear. Objectives To evaluate reproducibility of positive reactions to identical haptens tested simultaneously in different series and analyse doubtful reactions using paired co‐reactivity patterns. Materials and Methods Patch test data from consecutive patients tested during 2015–2025 were analysed retrospectively. Six haptens were evaluated at standard concentrations in petrolatum: hydroxyisohexyl 3‐cyclohexene carboxaldehyde (Lyral, HICC) 5% pet., Amerchol L‐101 50% pet., lanolin alcohol 30% pet., hydroxyethyl methacrylate (HEMA) 2% pet., mercaptobenzothiazole (MBT) 2% pet. and Myroxylon pereirae resin (balsam of Peru, MPR) 25% pet. Results Reproducibility was hapten‐dependent. HEMA and MBT showed substantial to almost perfect agreement. HICC showed substantial agreement but a significantly higher positivity rate in the perfume series than in the baseline series. Amerchol L‐101, lanolin alcohol and MPR showed lower positive agreement and fair‐to‐moderate kappa values. Most doubtful reactions were isolated, particularly for Amerchol L‐101 and lanolin alcohol, whereas 43.8% of doubtful HICC reactions in the baseline series were supported by perfume‐series reactivity. Conclusions Reproducibility was strongly hapten‐dependent. In this dataset, paired co‐reactivity provided clinical context for interpreting discordant positive and doubtful reactions.

Znanje koje odgovara vašem radu.

Od besplatnog početka i osobnog pretraživanja literature do potpunog paketa Research Suite.

Prikaži tarife →

Jesu li uključeni svi cjeloviti tekstovi izdavača?

Ne. Bibliografski zapisi, sažeci i cjeloviti tekstovi različiti su sadržaji. Hoće li cjeloviti tekst biti dostupan ovisi o izvoru, Open Accessu i vašim postojećim licencama. Tarifa EUVIMED ne zamjenjuje dodatna izdavačka prava.

Prikaži tarife →